CARLOS
CAMPS HERRERO
EMÉRITO/A UNIVERSIDAD
Hospital Universitario de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Cruces (11)
2023
-
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine, Vol. 389, Núm. 6, pp. 504-513
2018
-
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
British Journal of Cancer, Vol. 119, Núm. 12, pp. 1464-1470
2016
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558
2014
-
Bladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation
Health and Quality of Life Outcomes, Vol. 12, Núm. 1
-
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: The BRCA1-RAP80 Expression Customization (BREC) studies
Annals of Oncology, Vol. 25, Núm. 11, pp. 2147-2155
2010
-
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients
Lung Cancer, Vol. 68, Núm. 3, pp. 491-497
2009
-
Screening for epidermal growth factor receptor mutations in lung cancer
New England Journal of Medicine, Vol. 361, Núm. 10, pp. 958-967
2006
-
The place of targeted therapies in the management of non-small cell bronchial carcinoma: Molecular markers as predictors of tumor response and survival in lung cancer
Revue des Maladies Respiratoires, Vol. 23, Núm. 5 C3
2004
-
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer
Clinical Lung Cancer, Vol. 5, Núm. 6, pp. 360-365
-
Single nucleotide polymorphisms and outcome in docetaxel - Cisplatin-treated advanced non-small-cell lung cancer
Annals of Oncology, Vol. 15, Núm. 8, pp. 1194-1203
2003
-
Influence of genetic markers on survival in non-small cell lung cancer
Drugs of Today, Vol. 39, Núm. 10, pp. 775-786